We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Spirax-sarco Engineering Plc | LSE:SPX | London | Ordinary Share | GB00BWFGQN14 | ORD 26 12/13P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -40.00 | -0.44% | 9,135.00 | 9,130.00 | 9,135.00 | 9,205.00 | 9,120.00 | 9,165.00 | 9,593 | 12:50:58 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Automatic Regulatng Controls | 1.68B | 183.6M | 2.4946 | 36.60 | 6.72B |
From May 2019 to May 2024
TIDMSPX
RNS Number : 7131J
Spirax-Sarco Engineering PLC
09 April 2015
9th April 2015
Spirax-Sarco acquires ASEPCO Corporation
Spirax-Sarco Engineering plc, the world leader in the control and efficient use of steam, and in peristaltic pumping and associated fluid path technologies, announces that it has acquired the entire issued share capital of ASEPCO(R) Corporation (Asepco) for GBP7.0 million. Asepco will operate as part of our Watson-Marlow Fluid Technology Group (WMFTG).
Asepco, based in Mountain View, California USA, specialises in the design and manufacture of high purity aseptic valves and magnetic mixers for the biopharmaceutical industry. We are pleased that Steve Joy will continue in his role as President.
Asepco is a natural extension of the WMFTG fluid path product portfolio and further strengthens WMFTG's already strong global presence in the biotechnology and pharmaceutical industries. Asepco utilises patented, market-leading technology to improve sterility within the biotechnology production process, thereby reducing validation risk in demanding contamination-free applications; resulting in improved process sterility confidence for our customers.
The purchase consideration excludes any cash or debt balances and will be financed from the Group's existing cash resources. The acquisition is expected to provide a small benefit to Group earnings per share from 2015.
Enquiries:
Nick Anderson, Chief Executive
David Meredith, Director Finance
Tel: 01242 535234
About Spirax Sarco
Spirax-Sarco Engineering plc is the world leader in each of its two businesses, Spirax Sarco for steam specialties and Watson-Marlow Fluid Technology Group for niche peristaltic pumps and associated fluid path technologies. The steam specialties business provides a broad range of fluid control products, engineered packages, site services and systems expertise for a diverse range of industrial and institutional customers. The company helps its customers to improve production efficiency, reduce energy costs, water usage and emissions, improve product quality and enhance the safety of their operations. Watson-Marlow Fluid Technology Group offers the ideal solution for a wide variety of demanding fluid path applications with highly accurate, controllable and virtually maintenance free pumps and associated technologies. The Group is headquartered in Cheltenham, England, has strategically located manufacturing plants around the world and employs approximately 4,800 people, of whom around 1,300 are direct sales and service engineers. Its shares have been listed on the London Stock Exchange since 1959 (symbol: SPX).
Further information can be found at www.spiraxsarcoengineering.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
ACQEAXLNEADSEEF
1 Year Spirax-sarco Engineering Chart |
1 Month Spirax-sarco Engineering Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
